Genetic characterization of measles vaccine strains

Bettina Bankamp1, Makoto Takeda, Yan Zhang

  • 1Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. bbankamp@cdc.gov

Insights

Comparing measles vaccine genomes revealed genetic differences from wild-type virus. These substitutions in viral proteins are key to understanding measles vaccine attenuation and improving their efficacy.

Area of Science:

  • Virology
  • Genomics
  • Vaccinology

Background:

  • Measles remains a significant global health concern, necessitating effective vaccination strategies.
  • Understanding the genetic basis of measles vaccine attenuation is crucial for vaccine development and efficacy.

Purpose of the Study:

  • To compare the complete genomic sequences of nine measles vaccine strains with the Edmonston wild-type virus.
  • To identify nucleotide and amino acid substitutions responsible for measles vaccine attenuation.

Main Methods:

  • Whole-genome sequencing of nine measles vaccine strains and the Edmonston wild-type virus.
  • Bioinformatic analysis to identify nucleotide substitutions in coding and noncoding regions.
  • In vitro assays and recombinant viruses to characterize viral protein functions and attenuation mechanisms.

Main Results:

  • Identified nucleotide substitutions across all coding and noncoding regions in vaccine strains compared to wild-type.
  • Deduced amino acid substitutions in all eight viral proteins, indicating widespread genetic alterations.
  • Highlighted the significant role of substitutions affecting host cell tropism, virus assembly, and immune evasion in attenuation.

Conclusions:

  • Measles vaccine genomes exhibit substantial genetic divergence from wild-type strains.
  • Multiple viral proteins contribute to the attenuated phenotype of measles vaccines.
  • Specific substitutions influencing viral tropism, assembly, and immune evasion are critical for attenuation.